LELale Gonenir Erbay

Lale Gonenir Erbay

*This is an algorithmically generated author record based on publicly available information.

Lale Gonenir Erbay has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Effect of Septorhinoplasty on Psychopathology and Quality of Life

    by Pınar Tekin, YükSel Toplu, Lale Gönenir Erbay

    Background: The purpose was to assess the impact of septorhinoplasty on psychopathology and well-being and to demonstrate the effectiveness of septorhinoplasty and emphasize the importance of considering psychopathological status when selecting patients. Methods: Seventy patients scheduled for septorhinoplasty were evaluated prospectively. Following patient selection, participants were asked to complete a sociodemographic questionnaire, the Beck Anxiety Inventory (BAI), the Beck Depression Inventory, the Nasal Obstruction Symptom Evaluation Scale (NOSE), the Short Form-36 (SF-36), and the Rhinoplasty Outcome Evaluation Questionnaire (ROE) preoperatively and at 6 months postoperatively. Results: The mean age in the study was calculated as 26.14 Å} 6.80. The postoperative NOSE and BAI scores of the patients decrease, while ROE score increases (P < .05). An increase in physical role, physical function, general health, and social functioning scores was also found in SF-36 subscales (P < .05). There was an inverse correlation between preoperative depression levels and postoperative satisfaction. Conclusion: Septorhinoplasty has a positive effect on quality of life and anxiety. When selecting a patient, attention should be paid to the level of depression. Cite this article as: Tekin P, Toplu Y, G.nenir Erbay L. The effect of septorhinoplasty on psychopathology and quality of life. Eurasian J Med. 2026, 58(1), 1146, doi:10.5152/eurasianjmed.2026.251146.


  • Open Access

    Evaluation Of Morbid Obese Patients In Terms Of Sexual Dysfunctions: A Cross-Sectional Study

    by Bülent Yaprak, İbRahim Şahi̇n, Bahri Evren, Lezzan Keski̇n, Lale Göneni̇r Erbay

    Aim: Obesity is a risk factor for sexual dysfunction. The aim of this study was to determine the frequency of sexual dysfunction in patients diagnosed with morbid obesity.Methods: The patient group included in the study consisted of 78 morbidly obese patients with BMI≥40 kg/m2 and 68 healthy individuals with normal BMI. The data were obtained by using the sociodemographic information form filled by the participants, Beck anxiety scale, Beck depression scale and Golombok Rust Sexual Satisfaction Inventory.Results: Obese individuals were found to have sexual dysfunction compared to individuals with normal body BMI (p<0.05). When the Golombok Rust subscale scores of obese men were compared to those of normal-weight individuals, a significant deterioration was found in all subscale scores, including frequency, communication, satisfaction, avoidance, touch, impotence and premature ejaculation. In addition, the anxiety and depression scores of obese individuals were shown to be higher than those of normal-weight individuals (p<0.05).Conclusion: Morbidly obese individuals should be evaluated in terms of sexual functions. We believe that regulating obesity treatment, including possible treatment for sexual dysfunction, will increase the success rate and enhance the quality of life for patients.

  • Open Access

    Does Psychodrama Affect Perceived Stress, Anxiety-Depression Scores and Saliva Cortisol in Patients with Depression?

    by Lale Gönenir Erbay, İsmail Reyhani, Süheyla Ünal, Cemal Özcan, Tuba Özgöçer, Cihat Uçar, Sedat Yıldız

    Little is known about the effects of psychodrama group therapy on the level of stress, anxiety and depression of the group members, and the biological markers of stress. The aim of this study test cortisol level as a biological reflection of some mental characteristics gained by the psychodrama method in coping with stress. Depressive patients aged between 18 and 65 years, who diagnosed with depression according to DSM-5, without psychiatric comorbidity, who do not use drugs and were available for psychodrama were enrolled into the study. These patients were evaluated using the Perceived Stress Scale, State-Trait Anxiety Inventory and Beck Depression Inventory. In order to observe the circadian rhythm of cortisol, samples were collected from the participants before lunch, before dinner and before going to sleep on the day before psychodrama and on the 0, 15th, and 30th minutes after awakening in the morning of the psychodrama day; as well as just before and after the psychodrama session. Saliva cortisol level just before the initial session of psychodrama group therapy was compared with the saliva cortisol level just after the last psychodrama session at the end of 16 weeks. Statistically significant difference was determined between the scores of perceived stress scale, STAI-1, STAI-2, beck depression inventory and salivary cortisol level before and after psychodrama session. There was significant decrease in both the scale scores and salivary cortisol after vs. before psychodrama. This results is important as it shows the biological aspect of clinical improvement. Further studies would provide us with better understanding of the effects of psychodrama group psychotherapy on depressive mood and biological projections by means of short-term and long-term follow-up studies.


  • Open Access

    Bulimia nervosa following bariatric surgery: a case report

    by Lale Gonenir Erbay, Ibrahim Sahin, Cuneyt Kayaalp, Rifat Karlidag

  • Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF- and #945;, and IFN- and #947; levels in drug-free, comorbidity-free obsessive-compulsive disorder patients

    by Lale Erbay, Nursel Kavuran, Çağatay Taşkapan, Lara İnCe, Saim Yoloğlu, Hüsniye Temelli, Süheyla Nal


  • Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia

    by Sukru Kartalci, Aysun Bay Karabulut, Lale Gonenir Erbay, Ceren Acar

    Objectives: Electroconvulsive therapy (ECT) is the most effective option for several psychiatric conditions, including treatment-resistant schizophrenia. However, little is known about the molecular mechanism of action of ECT. The link between inflammatory system and schizophrenia is the focus of recent studies. However, the impact of ECT on inflammatory functioning in this disorder remains elusive. Whether ECT could modulate inflammatory factors in patients with schizophrenia was examined.Methods: Plasma levels of interleukin-4 (IL-4), transforming growth factor-β (TGF-β), myeloperoxidase (MPO), and nuclear factor-κB (NF-κB) activation were analyzed in 20 schizophrenic patients, mainly with resistant to antipsychotic medication disorders, and in 20 sex- and age-matched healthy controls. Disease severity was evaluated using the Brief Psychiatric Rating Scale. All patients were followed with measurement of the inflammatory factors before and after ECT treatment and compared with the controls.Results: Patients with schizophrenia had markedly raised NF-κB and but decreased TGF-β levels compared with healthy controls. On the other hand, no significant differences were found for the levels of IL-4 and MPO levels. The clinical improvement during repeated ECT was accompanied by a gradual and significant increase in IL-4 and TGF-β level, but MPO and NF-κB activation were left unaffected. Increases in TGF-β were negatively correlated with the change in Brief Psychiatric Rating Scale scores after ECT.Conclusions: It is shown that ECT, while increasing the anti-inflammatory response such as the levels of IL-4 and TGF-β, it did not affect the levels of MPO and NF-κB activation in this study.


  • Testosterone and DHEA-S levels with chronic tic disorder in children

    by Lale Gonenir Erbay, Şükrü Kartalci, Ozlem Ozel Ozcan, Arzu Çaliskan Demir, Ayse Burcin Uyumlu, Meryem Ozlem Kutuk


  • Open Access

    Urinary retention in male patient associated with aripiprazole

    by Lara Utku Ince, Lale Gonenir Erbay, Suheyla Unal

  • IL-4, TGF-ß, NF-kB and MPO Levels in Patients With Treatment Resistant Schizophrenia

    by Sukru Kartalci, Lale Gonenir Erbay, Esra Porgali Zayman, Onder Otlu, Aysun Bay Karabulut

    Schizophrenia is a chronic psychotic disorder in which genetics and environmental factors such as infection and the corresponding immune response play a role in the etiopathogenesis. The aim of this study was to compare some immune factors such as nuclear factor-B (NF-B) activation, myeloperoxidase (MPO), the anti-inflammatory cytokine interleukin-4 (IL-4), and regulatory cytokine transforming growth factor- (TGF-) in schizophrenia patients and an age- and gender-matched control group. Plasma levels of IL-4, TGF-, MPO, and NF-B activation in 20 subjects with treatment-resistant schizophrenia and 20 age- and gender-matched healthy controls were analyzed. Disease severity was evaluated using the Brief Psychiatric Rating Scale (BPRS). Plasma TGF- levels were found to be significantly lower and NF-B to be significantly higher in antipsychotic treatment-resistant schizophrenia patients than in controls in this study. No significant differences were found between the patient and control groups for serum IL-4 and MPO levels. The low TGF- level in treatment-resistant schizophrenia patients in the symptom exacerbation period indicates that there is inadequate Th1/Th2 balance. Large-scale studies are required to investigate whether this is responsible for resistance in schizophrenia. The fact that the increase in NF-B that we found in treatment-resistant schizophrenia patients in this study has also been reported in the first attack in untreated schizophrenia patients in previous studies indicates that NF-B plays a role in the disorder's physiopathology from the beginning.